Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors

NCT01944046 is registered in ClinicalTrials.gov with Linmarie Sikich as lead sponsor.

NCT NCT01944046
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01944046 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors
Lead sponsor
Linmarie Sikich
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2014
Completion date
November 30, 2017
Enrollment
290 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

autism spectrum disorders